Correlation Between Arbutus Biopharma and Ayala Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Arbutus Biopharma and Ayala Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arbutus Biopharma and Ayala Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arbutus Biopharma Corp and Ayala Pharmaceuticals, you can compare the effects of market volatilities on Arbutus Biopharma and Ayala Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arbutus Biopharma with a short position of Ayala Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arbutus Biopharma and Ayala Pharmaceuticals.

Diversification Opportunities for Arbutus Biopharma and Ayala Pharmaceuticals

-0.42

Correlation Coefficient

Arbutus Biopharma  Ayala Pharmaceuticals

Very good diversification

The 3 months correlation between Arbutus and Ayala is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Arbutus Biopharma Corp and Ayala Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ayala Pharmaceuticals and Arbutus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arbutus Biopharma Corp are associated (or correlated) with Ayala Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ayala Pharmaceuticals has no effect on the direction of Arbutus Biopharma i.e., Arbutus Biopharma and Ayala Pharmaceuticals go up and down completely randomly.

Pair Corralation between Arbutus Biopharma and Ayala Pharmaceuticals

If you would invest  249.00  in Arbutus Biopharma Corp on January 25, 2024 and sell it today you would earn a total of  26.00  from holding Arbutus Biopharma Corp or generate 10.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	4.76%
Values	Daily Returns

Arbutus Biopharma Corp  vs.  Ayala Pharmaceuticals

Arbutus Biopharma Corp

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Arbutus Biopharma Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Arbutus Biopharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Ayala Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ayala Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Ayala Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Arbutus Biopharma and Ayala Pharmaceuticals

The main advantage of trading using opposite Arbutus Biopharma and Ayala Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arbutus Biopharma position performs unexpectedly, Ayala Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayala Pharmaceuticals will offset losses from the drop in Ayala Pharmaceuticals' long position.

The idea behind Arbutus Biopharma Corp and Ayala Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.